“The stem cells were unable to self-renew, which resulted in long-term and irreversible impairment of tumour growth. In other words, the cancer was permanently shut down.”
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
“This is the first step toward clinically applying the principles of cancer stem cell biology to control cancer growth and advance the development of durable cures,” says principal investigator Dr. John Dick about the findings published online today in Nature Medicine.
He talks about the research in this video.
https://www.youtube.com/watch?v=QK7JquljkBc.
Dr. Dick pioneered the cancer stem cell field by first identifying leukemia stem cells (1994) and colon cancer stem cells (2007). He is also renowned for isolating a human blood stem cell in its purest form – as a single stem cell capable of regenerating the entire blood system – paving the way for clinical use (2011). Dr. Dick holds a Canada Research Chair in Stem Cell Biology and is a Senior Scientist at University Health Network’s Princess Margaret Cancer Centre and McEwen Centre for Regenerative Medicine. He is also a Professor in the Department of Molecular Genetics, University of Toronto, and Director of the Cancer Stem Cell Program at the Ontario Institute for Cancer Research.
In pre-clinical experiments, the research team replicated human colon cancer in mice to determine if specifically targeting the stem cells was clinically relevant. First, the researchers identified that the gene BMI-1, already implicated in maintaining stem cells in other cancers, is the pivotal regulator of colon cancer stem cells and drives the cycle of self-renewal, proliferation and cell survival. Next, the team used an existing small-molecule inhibitor to successfully block BMI-1, thus demonstrating the clinical relevance of this approach.
Lead author Dr. Antonija Kreso writes: “Inhibiting a recognized regulator of self-renewal is an effective approach to control tumor growth, providing strong evidence for the clinical relevance of self-renewal as a biological process for therapeutic targeting.”
Dr. Dick explains: “When we blocked the BMI-1 pathway, the stem cells were unable to self-renew, which resulted in long-term and irreversible impairment of tumour growth. In other words, the cancer was permanently shut down.”
The Latest Google Headlines on: Colon cancer
[google_news title=”” keyword=”Colon cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on: Colon cancer
- The Kentucky program helping more people get colon cancer screeningson March 28, 2024 at 6:01 pm
In this month’s Link to Hope, how a partnership between Kentucky CancerLink and doctors statewide is helping get more people screened.
- Colon cancer symptoms listed as rise in number of young people diagnosed 'becoming bigger problem'on March 28, 2024 at 4:13 pm
Rising colon and rectal cancer rates in youngsters are ‘becoming a bigger problem every year’ and it's one of the US' biggest cancer killers in under-50si. The CDC outlines its symptoms ...
- Marion woman triumphs over colon cancer with advanced immunotherapy clinical trialon March 28, 2024 at 4:02 pm
A Marion woman is winning her fight against cancer thanks to a clinical treatment that doesn't require surgery and uses her immune system to detect and target c ...
- Milwaukee surgeon sees rise in colorectal cancer cases affecting young adultson March 28, 2024 at 3:43 pm
Aurora Health Dr. Kate Vasconcellos says she is seeing a concerning trend of patients in their 20s and 30s with colorectal cancer.
- Colorectal Cancer Awareness month, bringing awareness to the 2nd leading cause of cancer death in Wyomingon March 28, 2024 at 1:21 pm
Colorectal cancer is the third most common cancer in the U.S., with it being the second leading cause of cancer deaths in the U.S. and in Wyoming.
- Colon Cancer Awareness Monthon March 28, 2024 at 11:13 am
Dr. Nolan Perez with Texas Digestive Specialists in Harlingen spoke to ValleyCentral about Colon cancer. March is Colon Cancer Awareness Month and many people ...
- Breakthroughs in medicine: colon cancer awarenesson March 28, 2024 at 10:51 am
CINCINNATI (WKRC) - A surgeon at The Christ Hospital is speaking up about colon cancer awareness, but also what she hopes all of us know even if this cancer is discovered and treated.
- Boston launches colon cancer awareness campaign focused on predominantly Black communitieson March 28, 2024 at 8:50 am
The Boston Public Health Commission launched a campaign this week aimed at increasing awareness about colon cancer screening and the ways to combat one of the few known preventable cancers. The ...
- What millennials need to know about colon cancer: Q&A with Dr. Jon LaPookon March 28, 2024 at 7:42 am
Dr. Jon LaPook explains new study on colonoscopies and colon cancer deaths 04:26. Colon cancer rates continue to rise in younger age groups, prompting questions about signs to loo ...
- Beyond the scope: Temple Health providers aim to increase access and awareness of colon cancer screening optionson March 27, 2024 at 7:51 pm
Fecal immunochemical tests, or FIT, are stool-based screenings that can be used at home to detect early signs of colorectal cancer.
The Latest Google Headlines on: Therapeutic stem cells
[google_news title=”” keyword=”therapeutic stem cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on: Therapeutic stem cells
- Heart Health: Understanding Stem Cells And Its Role In Cardiac Careon March 28, 2024 at 12:29 am
Stem cell therapy holds tremendous potential to revolutionise cardiac care by offering a regenerative approach to treating heart diseases Read on ...
- FDA Approves First Gene Therapy to Treat Children with Metachromatic Leukodystrophyon March 27, 2024 at 5:01 pm
On March 18, 2024, the FDA approved Orchard Therapeutics’ LENMELDY, the first approved gene therapy for the treatment of children ... is made from patient’s own hematopoietic (blood) stem cells, and ...
- Instructing iPS cell-derived mesenchymal stem cells to inhibit abnormal bone formation in FOPon March 27, 2024 at 1:49 pm
A team of researchers led by Associate Professor Makoto Ikeya (Department of Clinical Application) has observed early signs of success from providing iPSC-derived mesenchymal stem/stromal cells (iMSCs ...
- Antibody therapy makes the immune systems of old mice young againon March 27, 2024 at 9:00 am
A novel antibody therapy makes the immune system of old mice appear younger, allowing the animals to better fend off infections and reduce inflammation ...
- Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Managementon March 27, 2024 at 5:00 am
Company expected to receive significant new capital from Highbridge to bolster the commercialization of allogeneic stem cell transplant Omisirge® ...
- Antibody Therapy Rejuvenates Aging Mouse Immune System, Boosting Vaccine Responseon March 26, 2024 at 5:00 pm
This finding changes how we think about stem cells during every stage of aging.” Writing in their paper, the investigators further noted that their findings could feasibly have applications in a range ...
- Integrating New Therapies With Autologous Stem Cell Transplant in Myelomaon March 26, 2024 at 10:00 am
Saad Z. Usmani, MD, MBA, FACP, FASCO, discussed how the role of autologous stem cell transplant is evolving in the myeloma treatment landscape with the emergence of CAR T-cell therapies and ...
- Therapeutic Solutions International files patent for stem cell therapy for degenerative conditionson March 26, 2024 at 5:39 am
Discover a groundbreaking patent by Therapeutic Solutions International Inc. for gene-edited pluripotent stem cells to treat degenerative and autoimmune diseases. Learn about the innovative method ...
- Opinion: The revolutionary sickle cell therapieson March 21, 2024 at 9:28 am
In December, the FDA approved the first two cell-based gene therapies for treating sickle cell disease: Casgevy and Lyfgenia. And, like any emerging medical technology, the initial use of the ...
- Lifesaving gene therapy for kids is world’s priciest drug at $4.25Mon March 20, 2024 at 1:53 pm
In a medical triumph, the US Food and Drug Administration on Monday approved a gene therapy that appears to trounce a rare, tragic disease that progressively steals children's ability to talk, move, ...